Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs00566905

Ligand	Ligand name	Chain	PDB	Tanimoto
CAU	(2S)-1-(9H-Carbazol-4-yloxy)-3-(isopropylamino)propan-2-ol	A	2RH1	0.71
LX2	[4-(3-{[2-chloro-3-(trifluoromethyl)benzyl](2,2-diphenylethyl)amino}propoxy)-1H-indol-1-yl]acetic acid	A,B,C,D	3FC6	0.7
SRO	SEROTONIN	A,B	3BRN	0.71
SRO	SEROTONIN	A	2QEH	0.71
FLD	BIS-(N-ETHYLPYRIDINIUM-(3-METHOXYCARBAZOLE))HEXANE-1,6-DIAMINE	A,B	154D	0.75
ET0	3-(5-methoxy-1H-indol-3-yl)propanoic acid	A,B	3ET0	0.72
6EA	(1S)-1-(1H-INDOL-3-YLMETHYL)-2-(2-PYRIDIN-4-YL-[1,7]NAPHTYRIDIN-5-YLOXY)-EHYLAMINE	E	2F7Z	0.73
228	N-[2-(1,3-BENZODIOXOL-5-YL)ETHYL]-1-[2-(1H-IMIDAZOL-1-YL)-6-METHYLPYRIMIDIN-4-YL]-D-PROLINAMIDE	A	2ORO	0.71
PUX	8-BENZO[1,3]DIOXOL-,5-YLMETHYL-9-BUTYL-2-FLUORO-9H-PURIN-6-YLAMINE	A	1UYK	0.7
BER	BERBERINE	A	3D6Y	0.81
BER	BERBERINE	A,B,D,E	1JUM	0.81
BER	BERBERINE	A,B,D,E	3BTI	0.81
BER	BERBERINE	A	2QVD	0.81
232	1,3-DI[[[10-METHOXY-7H-PYRIDO[4,3-C]CARBAZOL-2-IUMYL]-ETHYL]-PIPERIDIN-4-YL]-PROPANE	A	1C9Z	0.73
CR3	2-{5-[AMINO(IMINIO)METHYL]-1H-INDOL-2-YL}-6-(CYCLOPENTYLOXY)BENZENOLATE	A	1O2H	0.7
43A	(3Z)-6-(4-HYDROXY-3-METHOXYPHENYL)-3-(1H-PYRROL-2-YLMETHYLENE)-1,3-DIHYDRO-2H-INDOL-2-ONE	A	2AYP	0.73
887	N-cyclopropyl-6-[(6,7-dimethoxyquinolin-4-yl)oxy]naphthalene-1-carboxamide	A,B	3B8R	0.71
RO0	1-(3,4-DIMETHOXYBENZYL)-6,7-DIMETHOXY-4-{[4-(2-METHOXYPHENYL)PIPERIDIN-1-YL]METHYL}ISOQUINOLINE	A	2FVJ	0.74
7PC	2-[4-(AMINOMETHYL)-2-CHLOROPHENOXY]-5-PYRIDIN-2-YLPHENOL	A,B	2OP0	0.7
4LG	METHYL (6-{[(2R)-1-(4-{3-[(2-METHOXYBENZYL)OXY]PROPOXY}PHENYL)-6-OXOPIPERAZIN-2-YL]METHOXY}-1H-INDOL-1-YL)ACETATE	A,B	2G27	0.73
P13	N-[2-(3-AMINOPROPOXY)-5-(1H-INDOL-5-YL)BENZYL]-N-(2-PIPERAZIN-1-YLETHYL)AMINE	B	1UTS	0.73
253	10,11-dimethoxy-4-methyldibenzo[c,f]-2,7-naphthyridine-3,6-diamine	A	2R7B	0.74
AI3	2,3-DIMETHOXY-12H-[1,3]DIOXOLO[5,6]INDENO[1,2-C]ISOQUINOLIN-6-IUM	A,C,D	1TL8	0.79
DIT	DITERCALINIUM	A	1D32	0.73
4EA	(1S)-2-(1H-INDOL-3-YL)-1-[({5-[(E)-2-PYRIDIN-4-YLVINYL]PYRIDIN-3-YL}OXY)METHYL]ETHYLAMINE	E	2F7X	0.71
I3N	1-BENZYL-5-METHOXY-2-METHYL-1H-INDOL-3-YL)-ACETIC ACID	A	1DCY	0.7
342	(3S)-1-(1,3-BENZODIOXOL-5-YLMETHYL)-3-[4-(1H-IMIDAZOL-1-YL)PHENOXY]PIPERIDINE	A	2ORT	0.72
PU6	8-BENZO[1,3]DIOXOL-,5-YLMETHYL-9-BUTYL-9H-	A	1UY9	0.7
Q4A	N-(1-benzylpiperidin-4-yl)-6,7-dimethoxy-2-(4-methyl-1,4-diazepan-1-yl)quinazolin-4-amine	A,B	3FPD	0.73
KIN	1-[4-(PYRIDIN-4-YLOXY)PHENYL]-3-[3-(TRIFLUOROMETHYL)PHENYL]UREA	A	2HZN	0.7
HRM	7-METHOXY-1-METHYL-9H-BETA-CARBOLINE	A	2Z5X	0.76
HRM	7-METHOXY-1-METHYL-9H-BETA-CARBOLINE	A	2Z5Y	0.76
3LG	(5-{[(2R)-1-(4-{3-[(2-METHOXYBENZYL)OXY]PROPOXY}PHENYL)-6-OXOPIPERAZIN-2-YL]METHOXY}-1H-INDOL-1-YL)ACETIC ACID	B	2G26	0.71
PFJ	6,7-DIMETHOXY-4-[(3R)-3-(QUINOXALIN-2-YLOXY)PYRROLIDIN-1-YL]QUINAZOLINE	A	2OVY	0.7
ML1	N-[2-(5-methoxy-1H-indol-3-yl)ethyl]acetamide	A,B	2QX4	0.74
ML1	N-[2-(5-methoxy-1H-indol-3-yl)ethyl]acetamide	A,B	2QX6	0.74
ML1	N-[2-(5-methoxy-1H-indol-3-yl)ethyl]acetamide	A,B	2QWX	0.74
CIA	6-BENZO[1,3]DIOXOL-5-YL-2-METHYL-2,3,6,7,12,12A-HEXAHYDRO-PYRAZINO[1',2':1,6]PYRIDO[3,4-B]INDOLE-1,4-DIONE	A,B	1UDU	0.75
CIA	6-BENZO[1,3]DIOXOL-5-YL-2-METHYL-2,3,6,7,12,12A-HEXAHYDRO-PYRAZINO[1',2':1,6]PYRIDO[3,4-B]INDOLE-1,4-DIONE	A	1XOZ	0.75
3ID	3H-INDOLE-5,6-DIOL	A	1F9B	0.73
3ID	3H-INDOLE-5,6-DIOL	A	1OYO	0.73
DTQ	4-[3-HYDROXYANILINO]-6,7-DIMETHOXYQUINAZOLINE	A	1DI8	0.72
307	6,7-DIMETHYL-3-[(METHYL{2-[METHYL({1-[3-(TRIFLUOROMETHYL)PHENYL]-1H-INDOL-3-YL}METHYL)AMINO]ETHYL}AMINO)METHYL]-4H-CHROMEN-4-ONE	A,C	2AZ5	0.71
MT4	5-{4-[(6,7-dimethoxyquinolin-4-yl)oxy]-3-fluorophenyl}-2-[(4-fluorophenyl)amino]-3-methylpyrimidin-4(3H)-one	A,B	3EFK	0.7
DEH	2,9-dihydroxy-3,10-dimethoxy-5,6-dihydroisoquino[3,2-a]isoquinolinium	A	3GSY	0.74
ML2	N-[2-(2-iodo-5-methoxy-1H-indol-3-yl)ethyl]acetamide	A,B	2QX9	0.7
ML2	N-[2-(2-iodo-5-methoxy-1H-indol-3-yl)ethyl]acetamide	A,B	2QX8	0.7